Live attenuated Salmonella strains are thought to be potential vaccines or vaccine vectors for delivery of recombinantly expressed vaccine antigens(Ags). A non-replicative recombinant mutant strain of Salmonella (rSalmonella) that expresses fragment C of tetanus toxin(Tox C)has been shown to be strongly immunogenic, causing induction of significant systemic and mucosal antibody(Ab)responses against the Tox C Ag. However, since previous studies reported that administration of live attenuated strains of Salmonella resulted in side effects, it is preferable to use inactivated bacterial vaccines. Thus, in this study, we assessed the immunogenicity of a heat-killed attenuated strain of rSalmonella. The results showed that oral immunization with heat-killed rSalmonella-Tox C induced tetanus toxoid(TT)-specific systemic IgM Ab responses at levels indistinguishable from those of mice administered live bacteria. However, rSalmonella-Tox C had to be administered at a 10-fold higher oral dose than live bacteria to produce similar levels of TTspecific IgM-forming cells. Even at this higher dose, heat-killed rSalmonella-Tox C induced TT-specific systemic IgG Ab responses that were significantly lower than those obtained in mice dosed with live bacteria. Furthermore, no anti-TT IgA response was detected in the intestinal secretions of mice that were orally dosed with heat-killed rSalmonella-Tox C. Markedly decreased numbers of TT-specific IgG-and IgA-producing cells were detected in the lymph nodes of mice immunized with rSalmonella-Tox C. These results suggest that heat-killed rSalmonella-Tox C may not be appropriate for use as an oral vaccine or vaccine vector.
Introduction
Vaccination via mucosal routes has considerable advantages for antigen(Ag)delivery systems in terms of triggering both mucosal and systemic immune responses, resulting in two layers of host protection against infectious diseases.
The mucosal immune response is the first line of defense at the point of entry of pathogenic bacteria, while the systemic immune response neutralizes pathogenic bacteria that have penetrated this barrier (1) .
Salmonella strains induce strong local and systemic immune responses, as well as cellular responses, and a live attenuated strain of Salmonella has been evaluated as a potential oral vaccine or vaccine vector for delivery of recombinantly expressed foreign Ags (2) (3) (4) . Attenuation has focused on strains mutated in the aro genes, which encode enzymes of the pre-chorismate metabolic pathway that are involved in aromatic compound biosynthesis (5, 6) . These genes are required for the survival and growth of Salmonella. Accordingly, aro mutant strains have limited replication capacity, which results in clinically insignificant host infection. Thus, aro mutant strains of Salmonella are potential candidates for live oral vaccines against salmonellosis. Moreover, these mutant strains may act as a carrier for delivery of heterologous Ags to the immune system to induce secretory IgA(SIgA)antibody(Ab)responses (7) (8) (9) .
A previous study (10) reported that recombinant Salmonella (rSalmonella) enterica serovar Typhi, an aro mutant strain, was highly immunogenic when administered to healthy adult inpatient volunteers. However, this immunization also caused fevers or bacteremia in some volunteers. Furthermore, oral immunization of calves with an aro mutant strain of rSalmonella enterica serovar Typhimurium resulted in mortality in one of eight vaccinated animals (11) . Thus, while live attenuated Salmonella strains may be of use, these live bacterial vaccines also may cause harmful side effects due to the potential for restoration of virulence. This fact suggested that inactivated bacteria may be preferable for use in vaccination. In this regard, a previous study reported that when mice were immunized with heat-killed aroA mutant Salmonella expressing fragment C of tetanus toxin at a dosage equivalent to that of the live strain, immune responses against challenge with tetanus toxin were completely abolished (12) . However, in that study, the tac promoter was employed for expression of fragment C. Other work has shown that the expression of fragment C is highly unstable when placed under control of the tac promotor (13) .
Therefore, Chatfield et al. (13) developed an aroA, aroD double mutant strain of Salmonella that stably expresses fragment C under control of nirB promoter; this strain is designated rSalmonella-Tox C. However, the immunogenic potency of heat-killed rSalmonella-Tox C(versus that of live rSalmonella-Tox C)was not defined.
SIgA Ab responses contribute substantially to host defense and homeostasis in the mucosal immune system by preventing adhesion and colonization of mucosal surfaces, such as in the gastrointestinal tract, by pathogenic bacteria (14) . Further, SIgA Abs play an important role in restricting local immune responses against commensal bacteria, and preventing the induction of damaging systemic immune responses (15) . Previously, we showed that Peyerʼs The present study employed rSalmonella-Tox C, a strain that stably expresses fragment C. Heat-killed rSalmonella-Tox C was evaluated for immunogenicity to assess the strainʼs efficacy as a potential oral vaccine. Notably, the immune responses induced in ten-fold higher dose of heatkilled rSalmonella-Tox C was compared with those obtained with live bacteria.
Materials and Methods
Mice C57BL/6 mice were obtained from Japan SLC, Inc. 
Oral immunization for heat-killed rSalmonella-Tox C
The rSalmonella enterica serovar Typhimurium BRD 847 strain used in this study is an aroA, aroD double mutant that expresses the nontoxic, immunogenic 50-kDa fragment C of tetanus toxin from plasmid pTETnir15 under control of the anaerobically inducible nirB promoter (13) . rSalmonella-Tox C were grown statically for 4 h at 37℃ in L-broth containing ampicillin (100 mg/ml), as described previously (9) . Heat-killed rSalmonella-Tox C then was prepared by incubation at 60℃ for 1 h. Mice were deprived of food for 2 h and then gastrically administered a single oral dose of 5 x immunized with heat-killed rSalmonella-Tox C (Fig. 3) .
These results indicated that intestinal SIgA Ab responses against rSalmonella-Tox C were not induced after administration of heat-killed rSalmonella-Tox C to mice.
Discussion
In the present study, the potential for using heat- Mice groups were immunized orally with 5 x 10 9 or 5 x 10 10 CFU of heat-killed rSalmonella-Tox C or 5 x 10 9 CFU of live rSalmonella-Tox C. Four weeks after immunization, plasma samples were collected and subjected to TT-specific ELISA. MNCs were isolated from spleen and MLNs, and then were subjected to ELISPOT assays in order to determine the numbers of TT-specific IgM AFCs. The values shown are the mean ± SD. *, p < 0.05 compared to those from mice administered live rSalmonella-Tox C. N.D. indicates that the TT-specific Ab response was not detected. Mice groups were immunized orally with 5 x 10 9 or 5 x 10 10 CFU of heat-killed rSalmonella-Tox C or 5 x 10 9 CFU of live rSalmonella-Tox C. Four weeks after immunization, plasma samples were collected and subjected to TT-specific ELISA. MNCs were isolated from spleen and MLNs, and then were subjected to ELISPOT assays in order to determine the numbers of TT-specific IgG AFCs. The values shown are the mean ± SD. *, p < 0.05 and **, p < 0.01 compared to those from mice administered live rSalmonella-Tox C.
was significantly reduced compared to that of live bacteria.
These data are in accordance with a previous reports that an orally administered inactivated vaccine against typhoid fever induced lower Ab levels, which were associated with negligible protection against challenge(4). Furthermore, heat-killed aro-deficient Salmonella expressing fragment C (under control of the tac promoter)failed to induce immune responses (12) . In contrast, many previous studies reported that heat-killed Salmonella is a potential vaccine against salmonellosis (2, (20) (21) (22) . The source of these discrepancies is not known. The immunogenicity of attenuated strain of Salmonella may be especially sensitive to heat treatment.
Alternatively, heat-killed Salmonella may provide adequate immunogenicity for vaccination against salmonellosis but not serve well as a vaccine vector for foreign Ags.
It is possible that heat treatment at 60℃ causes destruction of the Salmonella organism. However, a previous study showed that among 3 inactivation procedures (deoxycholate extraction at 37℃, heat treatment at 56℃ for 2 h, or heat treatment at 100℃ for 1 h), the second treatment yielded a Salmonella vaccine with the greatest efficacy in host protection (23) . In addition, multiple studies that have employed Salmonella killed by heating to around 60℃ for 1 h to evaluate efficacy as vaccine have shown that these vaccines were effective in host protection against salmonellosis (2, (20) (21) (22) . Moreover, when Previte compared immunogenicity among 4 inactivation procedures(killing by radiation, acetone, alcohol, or heat), heat-killed Salmonella showed higher potential in host protection against a high challenge dose (24) .
It is also possible that foreign Ags expressed by the rSalmonella vector are labile to heat treatment (25) . This Collectively, the data presented here demonstrate that heat treatment of an attenuated strain of Salmonella results in reduction of immunogenicity, and therefore a heat-killed attenuated strain of Salmonella may not be appropriate for use as a potential vaccine vector for recombinantly expressed foreign Ags.
